ORGO Organogenesis Holdings Inc. - Class A
$1.85
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
ORGO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.85
市值
$238M
P/E (TTM)
12.5
每股收益 (TTM)
$0.15
营收 (TTM)
$564M
股息收益率
—
ROE
13.9%
负债/权益
—
52周区间
$2 – $7
ORGO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$564M
2016-12-31
→
2025-12-31
EPS
$0.15
2018-12-31
→
2025-12-31
自由现金流
$-24M
2022-12-31
→
2025-12-31
利润率
6.6%
2022-12-31
→
2023-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ORGO
同行中位数
P/E (TTM)
12.5
88.5
P/S (TTM) (市销率 (TTM))
0.4
1.7
P/B (市净率)
0.8
3.6
Price / FCF (股价/自由现金流)
-9.7
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ORGO
同行中位数
Operating Margin (营业利润率)
7.9%
—
Net Profit Margin (净利润率)
6.6%
-35.8%
ROA
6.8%
-38.8%
ROE
13.9%
-61.0%
ROIC
11.7%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ORGO
同行中位数
Current Ratio (流动比率)
3.6
3.9
Quick Ratio (速动比率)
3.1
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ORGO
同行中位数
Revenue YoY (营收同比增长)
17.0%
—
Revenue CAGR 3Y (营收3年复合年增长率)
7.8%
—
Revenue CAGR 5Y (营收5年复合年增长率)
10.8%
—
EPS YoY
-66.7%
—
Net Income YoY (净利润同比增长)
4201.1%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ORGO
同行中位数
ORGO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
卖出
7 位分析师
- 强烈买入 0 0.0%
- 买入 0 0.0%
- 持有 4 57.1%
- 卖出 1 14.3%
- 强烈卖出 2 28.6%
12个月价格目标
1 位分析师 · 2026-08-16
最低
$2.00
最高
$2.00
中位数目标
$2.00
+8.1%
平均目标
$2.00
+8.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.06%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.73 | $-0.36 | -0.37% |
| 2026年3月31日 | $-0.41 | $-0.32 | -0.09% |
| 2025年12月31日 | $0.31 | $0.21 | 0.10% |
| 2025年9月30日 | $0.15 | $0.06 | 0.09% |
| 2025年6月30日 | $-0.10 | $-0.06 | -0.04% |
| 2025年3月31日 | $-0.10 | $-0.06 | -0.04% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Cost of Revenue | · | $116M | $106M | $105M | $114M | $87M | $76M | $69M | $61M | $48M | |
| Gross Profit | · | $366M | $327M | $346M | $353M | $251M | $185M | $125M | $137M | $91M | |
| R&D Expense | $45M | $50M | $44M | $40M | $31M | $20M | $15M | $11M | $9M | $6M | |
| SG&A Expense | $326M | $295M | $270M | $284M | $250M | $204M | $200M | $162M | $134M | $93M | |
| Operating Expenses | $519M | $483M | $421M | $324M | $281M | $224M | $215M | $176M | $143M | $99M | |
| Operating Income | $45M | $-1M | $13M | $22M | $72M | $27M | $-30M | $-52M | $-5M | $-9M | |
| Interest Expense | · | · | $2M | $2M | $7M | $11M | $9M | $11M | $8M | $6M | |
| Interest Income | · | · | · | · | · | · | · | $64.0K | $129.0K | $153.0K | |
| Other Non-op | $-5.0K | $20.0K | $57.0K | $-13.0K | $-13.0K | $97.0K | $13.0K | $162.0K | $-9.0K | $285.0K | |
| Pretax Income | $47M | $-3M | $10M | $20M | $63M | $18M | $-39M | $-65M | $-15M | $-15M | |
| Income Tax | $10M | $-4M | $5M | $5M | $-31M | $530.0K | $150.0K | $84.0K | $-7M | $65.0K | |
| Net Income | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| EPS (Basic) | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 | $0.16 | $-0.42 | $-0.94 | · | · | |
| EPS (Diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | · | · | |
| Shares (Basic) | 126,738,136 | 131,673,278 | 131,231,317 | 130,070,231 | 128,331,022 | 107,737,936 | 92,840,401 | 69,318,456 | · | · | |
| Shares (Diluted) | 130,248,412 | 131,673,278 | 132,746,727 | 132,383,152 | 133,662,659 | 111,360,831 | 92,840,401 | 69,318,456 | · | · | |
| EBITDA | $60M | · | $13M | $22M | · | · | · | · | · | · |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $94M | $136M | $104M | $102M | $114M | $84M | $60M | $21M | $2M | $1M | |
| Receivables | $217M | $110M | $82M | $89M | $82M | $57M | $39M | $34M | $28M | · | |
| Inventory | $30M | $26M | $28M | $25M | $25M | $28M | $23M | $13M | $14M | · | |
| Prepaid Expense | $18M | $14M | $10M | $5M | $5M | $5M | $3M | $2M | $4M | $395.8K | |
| Current Assets | $362M | $286M | $225M | $223M | $227M | $174M | $126M | $71M | $50M | $1M | |
| PP&E (Net) | $104M | $89M | $116M | $102M | $79M | $56M | $47M | $40M | $42M | · | |
| PP&E (Gross) | $165M | $140M | $130M | $100M | $89M | $88M | $83M | $79M | $79M | · | |
| Accum. Depreciation | $88M | $73M | $73M | $63M | $58M | $74M | $66M | $62M | $59M | · | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $26M | $26M | $26M | · | |
| Intangibles | $9M | $12M | $16M | $21M | $26M | $31M | $21M | $26M | $30M | · | |
| Other Non-current Assets | $9M | $5M | $6M | $2M | $2M | $670.0K | $884.0K | $579.0K | $735.0K | · | |
| Total Assets | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Accounts Payable | $32M | $29M | $31M | $32M | $29M | $23M | $28M | $19M | $19M | · | |
| Accrued Liabilities | $50M | $39M | $30M | $26M | $37M | $24M | $23M | $20M | $23M | $50.8K | |
| Short-term Debt | · | · | · | · | · | · | $0 | $3M | $0 | · | |
| Current Liabilities | $100M | $77M | $81M | $75M | $83M | $68M | $60M | $56M | $52M | $478.4K | |
| Capital Leases | $22M | $25M | $25M | $21M | $47M | $0 | $14M | $15M | $12M | · | |
| Other Non-current Liabilities | $1M | $894.0K | $1M | $1M | $2M | $8M | $7M | $6M | $2M | · | |
| Total Liabilities | $165M | $113M | $181M | $184M | $202M | $148M | $165M | $117M | $157M | $11M | |
| Long-term Debt | · | · | $67M | $71M | $74M | $70M | · | · | $52M | · | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $9.0K | $6.0K | · | |
| Paid-in Capital | · | · | · | · | · | $297M | · | · | · | · | |
| Retained Earnings | $-3M | $-40M | $-41M | $-45M | $-61M | $-155M | $-171M | $-130M | $-65M | $-233.9K | |
| Stockholders' Equity | $300M | $263M | $279M | $266M | $241M | $142M | $52M | $40M | $-15M | $-16M | |
| Liabilities + Equity | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Shares Outstanding | 126,951,876 | 125,730,236 | 131,316,396 | 130,919,129 | 128,680,192 | 127,731,833 | 104,870,886 | 91,261,413 | 66,983,139 | 63,872,058 |
现金流 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $14M | $10M | $6M | · | · | · | · | · | · | |
| Stock-based Comp | $13M | $11M | $9M | $7M | $4M | $2M | $936.0K | $1M | $919.0K | $473.0K | |
| Deferred Tax | $10M | $-11M | $2M | $2M | $-32M | $112.0K | $111.0K | $186.0K | $-7M | · | |
| Amort. of Intangibles | $3M | $3M | $5M | $5M | $5M | $4M | $6M | $4M | $2M | $2M | |
| Restructuring | $516.0K | $0 | $4M | $2M | $5M | $618.0K | · | · | · | · | |
| Other Non-cash | $-85M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $14M | $31M | $25M | $62M | $5M | $-34M | $-61M | $-3M | $-5M | |
| CapEx | $14M | $10M | $24M | $34M | $31M | $18M | $6M | $2M | $2M | $1M | |
| Investing Cash Flow | $-14M | $-10M | $-24M | $-34M | $-31M | $-23M | $-6M | $-2M | $-15M | $-1M | |
| Stock Issued | · | · | · | · | · | $65M | $50M | $92M | · | $304M | |
| Stock Repurchased | · | $25M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $304M | |
| Financing Cash Flow | $-17M | $28M | $-6M | $-2M | $-1M | $42M | $79M | $82M | $19M | $7M | |
| Net Change in Cash | $-42M | $32M | $1M | $-11M | $30M | $24M | $39M | $19M | $500.0K | $659.0K | |
| Taxes Paid | $5M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-24M | · | $7M | $-9M | · | · | · | · | · | · | |
| Levered FCF | · | · | $6M | $-11M | · | · | · | · | · | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 75.4% | 76.7% | · | · | · | · | · | · | |
| Operating Margin | 7.9% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| Net Margin | 6.6% | · | 1.1% | 3.4% | · | · | · | · | · | · | |
| Pretax Margin | 8.3% | · | 2.4% | 4.5% | · | · | · | · | · | · | |
| EBITDA Margin | 10.6% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| ROA | 6.8% | · | 1.1% | 3.5% | · | · | · | · | · | -0.13% | |
| ROE | 13.9% | · | 1.8% | 5.9% | · | · | · | · | · | -4.9% | |
| ROIC | 11.7% | · | 2.1% | 6.4% | · | · | · | · | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | · | 2.8 | 3.0 | · | · | · | · | · | 3.0 | |
| Quick Ratio | 3.1 | · | 2.3 | 2.6 | · | · | · | · | · | 2.2 | |
| Interest Coverage | · | · | 5.7 | 11.1 | · | · | · | · | · | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | · | 1.0 | 1.0 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | · | 4.0 | 4.2 | · | · | · | · | · | · | |
| Receivables Turnover | 3.4 | · | 5.1 | 5.2 | · | · | · | · | · | · |
增长率 9
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.0% | 11.3% | -3.9% | -3.5% | 38.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.8% | 1.0% | 8.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.8% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -66.7% | -82.9% | 366.7% | · | · | · | · | · | |
| EPS CAGR 3Y | 7.7% | · | -35.6% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.00% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 4201.1% | -82.6% | -68.2% | -83.5% | 446.6% | · | · | · | · | · | |
| Net Income CAGR 3Y | 33.6% | -79.1% | -34.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Net Income TTM | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| Market Cap | $658M | · | $537M | $352M | · | · | · | · | · | · | |
| P/E | 34.5 | -320.0 | 102.2 | 22.4 | 13.2 | 50.2 | -11.5 | -10.8 | -76.3 | · | |
| P/S | 1.2 | · | 1.2 | 0.8 | · | · | · | · | · | · | |
| P/B | 2.2 | · | 1.9 | 1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 2.5 | 1.8 | 2.3 | 1.6 | 6.4 | 11.7 | · | · | · | · | |
| P / Cash Flow | -63.8 | · | 17.4 | 14.2 | · | · | · | · | · | · | |
| P / FCF | -26.9 | · | 82.0 | -39.0 | · | · | · | · | · | · | |
| Earnings Yield | 2.9% | -0.31% | 0.98% | 4.5% | 7.6% | 2.0% | -8.7% | -9.3% | -1.3% | · |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44M | $37M | $226M | $151M | $101M | $87M | $127M | $115M | $130M | $110M | $100M | $109M | $117M | $108M | $116M | $117M | |
| Cost of Revenue | · | · | · | · | · | $24M | · | $27M | $29M | $29M | · | $26M | $26M | $27M | $27M | $26M | |
| Gross Profit | · | · | · | · | · | $63M | · | $88M | $101M | $81M | · | $83M | $91M | $81M | $88M | $91M | |
| R&D Expense | $18M | $15M | $10M | $13M | $10M | $11M | $12M | $10M | $16M | $13M | $12M | $10M | $11M | $11M | $11M | $10M | |
| SG&A Expense | $54M | $65M | $100M | $80M | $74M | $73M | $74M | $72M | $77M | $72M | $61M | $64M | $70M | $74M | $68M | $79M | |
| Operating Expenses | $95M | $106M | $186M | $130M | $114M | $113M | $145M | $109M | $144M | $85M | $180M | $75M | $81M | $85M | $80M | $89M | |
| Operating Income | $-51M | $-69M | $63M | $21M | $-13M | $-27M | $10M | $6M | $-14M | $-4M | $-1M | $8M | $10M | $-4M | $9M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $620.0K | $514.0K | · | $444.0K | $594.0K | $649.0K | · | $572.0K | |
| Other Non-op | $-26.0K | $38.0K | $-98.0K | $18.0K | $73.0K | $2.0K | $-27.0K | $52.0K | $-28.0K | $23.0K | $-25.0K | $31.0K | $28.0K | $23.0K | $6.0K | $5.0K | |
| Pretax Income | $-51M | $-68M | $63M | $21M | $-12M | $-26M | $10M | $6M | $-15M | $-4M | $-2M | $8M | $9M | $-5M | $9M | $1M | |
| Income Tax | $45M | $-15M | $20M | $-407.0K | $-2M | $-7M | $3M | $-7M | $3M | $-2M | $-1M | $4M | $4M | $-2M | $1M | $997.0K | |
| Net Income | $-96M | $-53M | $44M | $22M | $-9M | $-19M | $8M | $12M | $-17M | $-2M | $-569.0K | $3M | $5M | $-3M | $7M | $215.0K | |
| EPS (Basic) | $-0.77 | $-0.44 | $0.32 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| EPS (Diluted) | $-0.77 | $-0.44 | $0.31 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| Shares (Basic) | 128,674,548 | 127,797,013 | -253,292,751 | 126,881,709 | 126,853,536 | 126,295,642 | -265,336,948 | 132,575,301 | 132,573,153 | 131,861,772 | -262,458,405 | 131,312,483 | 131,293,398 | 131,083,841 | -259,257,332 | 130,903,160 | |
| Shares (Diluted) | 128,674,548 | 127,797,013 | -260,822,980 | 130,848,995 | 126,853,536 | 126,295,642 | -266,688,402 | 133,926,755 | 132,573,153 | 131,861,772 | -264,820,845 | 133,417,721 | 133,066,010 | 131,083,841 | -261,239,102 | 132,232,954 | |
| EBITDA | $-51M | $-65M | · | $21M | $-13M | $-23M | · | $10M | $-11M | $-4M | · | $8M | $10M | $-4M | · | $2M |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $91M | $94M | $64M | $73M | $110M | $136M | $94M | $90M | $89M | · | $98M | $89M | $89M | · | $107M | |
| Receivables | $101M | $117M | $217M | $169M | $120M | $103M | $110M | $101M | $106M | $96M | · | $89M | $94M | $92M | · | $93M | |
| Inventory | $29M | $28M | $30M | $40M | $33M | $29M | $26M | $27M | $27M | $28M | · | $28M | $25M | $26M | · | $25M | |
| Prepaid Expense | $20M | $29M | $18M | $23M | $28M | $18M | $14M | $15M | $11M | $14M | · | $10M | $8M | $10M | · | $5M | |
| Current Assets | $200M | $269M | $362M | $300M | $260M | $268M | $286M | $239M | $234M | $227M | · | $226M | $216M | $217M | · | $231M | |
| PP&E (Net) | $102M | $104M | $104M | $78M | $76M | $76M | $89M | $90M | $90M | $114M | · | $118M | $112M | $107M | · | $97M | |
| PP&E (Gross) | · | · | $165M | $135M | $132M | $128M | $140M | $144M | $146M | $131M | · | $128M | $119M | $116M | · | $99M | |
| Accum. Depreciation | · | · | $88M | $84M | $80M | $76M | $73M | $75M | $75M | $75M | · | $70M | $68M | $65M | · | $62M | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | · | $29M | $29M | $29M | · | $29M | |
| Intangibles | $3M | $3M | $9M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | · | $17M | $18M | $20M | · | $22M | |
| Other Non-current Assets | $23M | $16M | $9M | $14M | $9M | $6M | $5M | $5M | $6M | $7M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Accounts Payable | $29M | $29M | $32M | $40M | $30M | $25M | $29M | $24M | $29M | $23M | · | $27M | $27M | $30M | · | $38M | |
| Accrued Liabilities | · | · | $50M | $40M | $26M | $31M | $39M | $36M | $38M | $40M | · | $35M | $28M | $29M | · | $34M | |
| Current Liabilities | $57M | $76M | $100M | $90M | $66M | $65M | $77M | $77M | $86M | $83M | · | $81M | $73M | $76M | · | $89M | |
| Capital Leases | $21M | $22M | $22M | $24M | $25M | $26M | $25M | $23M | $23M | $24M | · | $39M | $40M | $40M | · | $43M | |
| Other Non-current Liabilities | $4M | $1M | $1M | $3M | $3M | $897.0K | $894.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $118M | $139M | $165M | $124M | $100M | $99M | $113M | $168M | $180M | $180M | · | $186M | $179M | $182M | · | $201M | |
| Long-term Debt | · | · | · | · | · | · | · | $62M | $64M | $65M | · | $68M | $69M | $70M | · | $73M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Retained Earnings | $-153M | $-56M | $-3M | $-47M | $-68M | $-59M | $-40M | $-48M | $-60M | $-43M | · | $-40M | $-44M | $-49M | · | $-53M | |
| Stockholders' Equity | $148M | $245M | $300M | $255M | $233M | $243M | $263M | $279M | $264M | $278M | $279M | $277M | $271M | $264M | $266M | $256M | |
| Liabilities + Equity | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Shares Outstanding | 128,674,548 | 128,674,548 | 126,951,876 | 126,911,442 | 126,853,536 | 126,853,536 | 125,730,236 | 132,576,502 | 132,574,238 | 132,539,340 | 131,316,396 | 131,312,616 | 131,311,852 | 131,226,387 | 130,919,129 | 130,915,099 |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | · | · | · | |
| Stock-based Comp | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | $45M | $-15M | $16M | $-4M | $-1M | $-1M | $-3M | $-2M | · | · | $2M | · | · | · | · | · | |
| Amort. of Intangibles | $433.0K | $6M | $798.0K | $842.0K | $841.0K | $842.0K | $834.0K | $834.0K | $834.0K | $901.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $96.0K | $-126.0K | $2M | $750.0K | $611.0K | |
| Other Non-cash | · | $82M | · | · | · | $-7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $21M | $39M | $3M | $-33M | $-20M | $11M | $9M | $5M | $-10M | $11M | $17M | $9M | $-5M | $8M | $5M | |
| CapEx | $1M | $3M | $5M | $2M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $6M | $7M | $8M | $11M | $10M | |
| Investing Cash Flow | $-1M | $-3M | $-5M | $-2M | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-3M | $-6M | $-7M | $-8M | $-11M | $-10M | |
| Financing Cash Flow | $-13M | $-20M | $-5M | $-10M | $-288.0K | $-2M | $34M | $-2M | $-2M | $-3M | $-2M | $-1M | $-1M | $-1M | $-2M | $26.0K | |
| Net Change in Cash | $-45M | $-2M | $30M | $-9M | $-37M | $-26M | $41M | $4M | $1M | $-15M | $6M | $9M | $93.0K | $-14M | $-5M | $-5M | |
| Free Cash Flow | · | $18M | · | · | · | $-24M | · | · | · | $-12M | · | · | · | $-13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-13M | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 72.6% | · | 76.7% | 77.6% | 73.9% | · | 76.2% | 77.6% | 75.3% | · | 77.6% | |
| Operating Margin | -116.5% | -185.1% | · | 13.7% | -12.4% | -30.9% | · | 5.4% | -10.7% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| Net Margin | -220.0% | -142.8% | · | 14.3% | -9.3% | -21.7% | · | 10.7% | -13.1% | -1.9% | · | 2.9% | 4.5% | -2.8% | · | 0.18% | |
| Pretax Margin | -116.3% | -183.9% | · | 14.0% | -11.7% | -29.7% | · | 5.1% | -11.2% | -4.0% | · | 7.0% | 7.8% | -4.3% | · | 1.0% | |
| EBITDA Margin | -116.5% | -173.8% | · | 13.7% | -12.4% | -26.9% | · | 8.5% | -8.1% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| ROA | -22.2% | -10.8% | · | 4.5% | -2.1% | -4.1% | · | 2.7% | -3.8% | -0.46% | · | 0.69% | 1.2% | -0.67% | · | 0.05% | |
| ROE | -50.5% | -21.8% | · | 8.1% | -3.8% | -7.2% | · | 4.4% | -6.4% | -0.78% | · | 1.2% | 2.0% | -1.2% | · | 0.10% | |
| ROIC | -65.1% | -21.9% | · | 8.3% | -4.3% | -8.1% | · | 4.8% | -6.2% | -0.67% | · | 1.2% | 2.1% | -0.97% | · | 0.12% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.5 | · | 3.3 | 4.0 | 4.1 | · | 3.1 | 2.7 | 2.7 | · | 2.8 | 2.9 | 2.9 | · | 2.6 | |
| Quick Ratio | 2.6 | 2.7 | · | 2.6 | 2.9 | 3.3 | · | 2.5 | 2.3 | 2.2 | · | 2.3 | 2.5 | 2.4 | · | 2.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -22.4 | -7.5 | · | 18.1 | 16.4 | -6.2 | · | 3.1 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Inventory Turnover | · | · | · | · | · | 0.8 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | |
| Receivables Turnover | 0.4 | 0.3 | · | 1.1 | 0.9 | 0.9 | · | 1.2 | 1.3 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.4 |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $333M | $376M | · | $454M | $433M | $442M | · | $464M | $466M | $443M | · | $450M | $463M | $443M | · | $449M | |
| Net Income TTM | $-137M | $-60M | · | $6M | $-33M | $-26M | · | $-4M | $-11M | $3M | · | $6M | $11M | $5M | · | $21M | |
| Market Cap | $313M | $305M | · | $536M | $464M | $548M | · | $379M | $371M | $376M | · | $418M | $436M | $280M | · | $424M | |
| P/E | -2.0 | -4.0 | · | -60.3 | -11.8 | -18.8 | · | -71.5 | -31.1 | 142.0 | · | 79.5 | 36.9 | 53.2 | · | 21.6 | |
| P/S | 0.9 | 0.8 | · | 1.2 | 1.1 | 1.2 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.6 | · | 0.9 | |
| P/B | 2.1 | 1.2 | · | 2.1 | 2.0 | 2.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.1 | · | 1.7 | |
| P / Tangible Book | 2.7 | 1.4 | · | 2.5 | 2.4 | 2.7 | · | 1.6 | 1.7 | 1.6 | · | 1.8 | 1.9 | 1.3 | · | 2.1 | |
| P / Cash Flow | · | 14.4 | · | · | · | -27.5 | · | · | · | -37.0 | · | · | · | -55.1 | · | · | |
| P / FCF | · | 17.0 | · | · | · | -23.3 | · | · | · | -30.4 | · | · | · | -22.1 | · | · | |
| Earnings Yield | -49.4% | -25.3% | · | -1.7% | -8.5% | -5.3% | · | -1.4% | -3.2% | 0.70% | · | 1.3% | 2.7% | 1.9% | · | 4.6% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $564M | $482M | $433M | $451M | $467M |
| 毛利率 % | — | — | 75.4% | 76.7% | — |
| 营业利润率 % | 7.9% | — | 2.9% | 5.0% | — |
| 净收入 | $37M | $861.0K | $5M | $16M | $94M |
| 稀释后每股收益 (EPS) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 3.6 | — | 2.8 | 3.0 | — |
| 速动比率 | 3.1 | — | 2.3 | 2.6 | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-24M | — | $7M | $-9M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 141 家申报者 · $93.2M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 37 (+20 与上一季度对比) | 14 (-26 与上一季度对比) | 40 (+10 与上一季度对比) | 33 (-11 与上一季度对比) | +967K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 19 位内幕人士 · 7 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Gary S. Gillheeney | President and CEO | 2025年2月19日 A | 3515323 | 0 | 0 | $0 |
| David Francisco | Chief Financial Officer | 2025年2月19日 A | 559095 | 0 | 0 | $0 |
| Patrick Bilbo | Chief Operating Officer | 2025年2月19日 A | 949062 | 0 | 0 | $0 |
| Brian Grow | Chief Commercial Officer | 2025年8月11日 M | 672377 | 0 | 0 | $0 |
| Robert Cavorsi | Vice President, Strategy | 2025年7月16日 F | 189165 | 0 | 0 | $0 |
| Lori Freedman | Chief Admin. and Legal Officer | 2025年6月6日 P | 846459 | 0 | 0 | $0 |
| Antonio S. Montecalvo | Vice President, Health Policy | 2025年2月19日 A | 196680 | 0 | 0 | $0 |
| Michael Joseph Driscoll | 董事 | 2025年3月4日 S | 166879 | 0 | 0 | $0 |
| Garrett Lustig | 董事 | 2025年2月19日 A | 76914 | 0 | 0 | $0 |
| Gilberto Quintero | 董事 | 2025年2月19日 A | 190245 | 0 | 0 | $0 |
| Prathyusha Duraibabu | 董事 | 2025年2月19日 A | 198219 | 0 | 0 | $0 |
| Michele Ilene Korfin | 董事 | 2025年2月19日 A | 190245 | 0 | 0 | $0 |
| Jon L Giacomin | 董事 | 2025年2月19日 A | 192198 | 0 | 0 | $0 |
| Arthur S Leibowitz | 董事 | 2025年2月19日 A | 237186 | 0 | 0 | $0 |
| Robert P O'Neil | 董事 | 2018年12月10日 D | — | 0 | 0 | $0 |
| Charles C Harwood Jr | 董事 | 2018年12月10日 D | — | 0 | 0 | $0 |
| Hakan Bjorklund | 董事 | 2018年12月10日 D | — | 0 | 0 | $0 |
| Brian A Markison | 董事 | 2018年12月10日 D | — | 0 | 0 | $0 |
| Michael W Katz | 10% 所有者 | 2022年11月21日 P | 76382 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Glenn H. Nussdorf, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 2025年11月3日 | 9.70% | 修订 | — | SEC |
| Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom, Organo PFG LLC, Organo Investors LLC, Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, Dennis Erani 2012 Issue Trust dated 12/20/12, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, RED Holdings, LLC, Josette Ades ×11 申报 | 2025年6月26日 | 17.60% | 修订 | — | SEC |
| Avista Healthcare Partners III, L.P., AHP III Orchestra Holdings, L.P., Avista Capital Partners VI GP, L.P., Avista Capital Managing Member VI, LLC, Thompson Dean, David Burgstahler | 2024年11月19日 | — | 初始申报 | 被动投资 | SEC |
| Avista Acquisition Corp., Avista Acquisition, LLC, Avista Capital Partners (Offshore) IV, LP, Avista Capital Partners IV, L.P., Avista Capital Managing Member IV, LLC, Avista Capital Partners IV GP L.P., Thompson Dean, David Burgstahler ×6 申报 | 2021年5月27日 | — | 初始申报 | — | SEC |
| Avista Acquisition Corp. (2), Avista Acquisition, LLC. (2), Avista Capital Partners (Offshore) IV, LP (2), Avista Capital Partners IV, L.P. (2), Avista Capital Managing Member IV, LLC (2), Avista Capital Partners, IV GP L.P. (2), Thompson Dean (2), David Burgstahler (2) | 2018年12月20日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 32 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| GSSC · Goldman Sachs ETF Trust | 0.02% | 86415 NS | 2026年5月31日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 147708 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 406571 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.00% | 29998 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.00% | 3214 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 350724 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 4647 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.00% | 2514 NS | 2026年5月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.00% | 134421 NS | 2026年4月30日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.00% | 73266 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.00% | 2541 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 334000 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2642 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 64 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 9772 NS | 2026年4月30日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 22383 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 45075 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 9486 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 9630 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFQY · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |